FIELD: medicine.
SUBSTANCE: group of inventions relates to the treatment of cancer. A nanoparticle complex for the treatment of cancer contains albumin, 20-acetoxy-4-deacetyl-5-epi-20,O-secotaxol and antibodies with an antigen-binding domain, where antibodies are bound to albumin through non-covalent bonds and are located on the outer surface of the nanoparticle complex, and where 20-acetoxy-4-deactyl-5-epi-20,O-secotaxol is less toxic than paclitaxel. A composition of nanoparticles, a method for destroying cancer cells in a population of cancer cells and a method for treating cancer in a patient in need are also disclosed.
EFFECT: group of inventions provides reduced toxicity.
17 cl, 17 dwg, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR COMBINATION THERAPY OF PROLIFERATIVE DISEASES | 2011 |
|
RU2577278C2 |
SOLID DISPERSIONS CONTAINING APOPTOSIS PROMOTING PROTEINS | 2010 |
|
RU2550134C2 |
NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT | 2008 |
|
RU2483714C2 |
NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | 2013 |
|
RU2678448C2 |
COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY | 2006 |
|
RU2452482C2 |
COMBINATIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY | 2013 |
|
RU2673805C2 |
COMBINATIONS AND METHODS FOR THERAPEUTIC AGENTS INTRODUCTION AND COMBINED THERAPY | 2012 |
|
RU2632103C2 |
COMPOSITIONS AND METHODS FOR TREATING DISEASE | 2007 |
|
RU2482877C2 |
RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF | 2015 |
|
RU2682335C2 |
METHODS OF TREATING PANCREATIC CANCER | 2011 |
|
RU2576609C2 |
Authors
Dates
2021-10-06—Published
2017-09-06—Filed